Investors in PetMed Express Suffer 46% Loss Over Last Five Years.
March 2, 2023
Trending News 🌧️
PETMED ($NASDAQ:PETS): Investors in PetMed Express have unfortunately seen a dramatic decrease in their investments over the past five years. With the stock falling by an approximate 46%, it is an undeniable fact that the last five years have not been a great time to be a PetMed Express investor. This recent slump in stock value has brought attention to the company’s ability to survive and remain profitable in the coming years. As a result of this downturn, analysts are beginning to become wary of investing in the company. With overall market sentiment being cautious and uncertain, it is clear that PetMed Express is going to have to prove itself to investors in order to gain back their trust and confidence in the company.
In addition, as the financial industry continues to experience rapid change and disruption, PetMed Express must be able to adapt and move forward in order to meet the changing demand. All in all, it has definitely been a difficult five years for PetMed Express investors. While the company still has potential, investors must take into account the recent downturn before deciding whether or not to invest in the company.
Stock Price
4 . Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Petmed Express. More…
| Total Revenues | Net Income | Net Margin |
| 260.45 | 11.4 | 4.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Petmed Express. More…
| Operations | Investing | Financing |
| 26.8 | -8.81 | -24.46 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Petmed Express. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 165.12 | 31.54 | 6.55 |
Key Ratios Snapshot
Some of the financial key ratios for Petmed Express are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -1.7% | -25.1% | 4.9% |
| FCF Margin | ROE | ROA |
| 8.8% | 5.9% | 4.8% |
Analysis
At GoodWhale, we recently conducted a financial analysis of PETMED EXPRESS and determined a Risk Rating for the company. Based on our assessment, PETMED EXPRESS is a medium risk investment when it comes to financial and business aspects. In particular, we have identified two risk warnings within the income statement and balance sheet that we believe investors should pay attention to. To get more detailed information on these warnings, we recommend registered users to sign up with GoodWhale. More…
Peers
PetMed Express Inc is one of the largest online pet pharmacies in the United States. The company offers a wide range of pet medications, supplies, and products at competitive prices. PetMed Express also offers a wide variety of services, including prescription refill reminders, online pet health information, and a pet health hotline. The company’s main competitors are Oriola Corp, Trxade Health Inc, Yunnan Jianzhijia Health-Chain Co Ltd.
– Oriola Corp ($LTS:0NER)
Oriola Corporation is a Finnish company that provides branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company has a market capitalization of €330.77 million and a return on equity of 7.73%. Oriola Corporation is a leading provider of branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company offers a wide range of products and services, including branded pharmaceuticals, generic pharmaceuticals, over-the-counter (OTC) products, medical devices, and services.
– Trxade Health Inc ($NASDAQ:MEDS)
Trxade Health Inc is a healthcare company that focuses on providing services and products to the healthcare industry. The company has a market cap of 8.16M as of 2022 and a Return on Equity of -110.47%. Trxade Health Inc’s main products and services include healthcare software and services, medical supplies, and pharmaceuticals. The company operates in the United States and Canada.
– Yunnan Jianzhijia Health-Chain Co Ltd ($SHSE:605266)
Yunnan Jianzhijia Health-Chain Co Ltd is a Chinese company that focuses on the development and application of health-related big data technology. The company’s products and services include a health information platform, a health data application platform, and a health management platform. As of 2022, Yunnan Jianzhijia Health-Chain Co Ltd has a market cap of 5.46B and a Return on Equity of 11.7%.
Summary
Investing in PetMed Express (PETS) over the past five years has been a losing proposition, with the stock suffering a 46% loss. Despite the financial hit, media coverage of the company has generally been positive. For those planning to invest, PETS should be analyzed closely to gauge the pros and cons. Investors should consider factors such as the company’s financial health, competitive landscape and risks associated with the stock. General research of the stock, its past history, and it’s outlook should be taken into account.
Additionally, investors should pay close attention to market trends and consider whether any investments in PETS would be a sound decision.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
